A Case Report of Unresectable Cutaneous Squamous Cell Carcinoma Responsive to Pembrolizumab, a Programmed Cell Death Protein 1 Inhibitor

作者:Chang Anne Lynn S*; Kim Jinah; Luciano Richard; Sullivan Chang Loretta; Colevas Alexander D
来源:JAMA Dermatology, 2016, 152(1): 106-108.
DOI:10.1001/jamadermatol.2015.2705